New registry to track myasthenia gravis drug safety in 1,500 patients
NCT ID NCT07217509
First seen Nov 01, 2025 · Last updated May 19, 2026 · Updated 29 times
Summary
This study is a registry that will follow about 1,500 adults with myasthenia gravis, a chronic nerve-muscle disease, to see how well their treatments work and what side effects occur. Participants receive no experimental drugs; instead, researchers collect data during regular doctor visits. The goal is to better understand the disease and improve future care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYASTHENIA GRAVIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CorEvitas, LLC
Waltham, Massachusetts, 02451, United States
Conditions
Explore the condition pages connected to this study.